Bhandari Priyanka, Durrance Richard Jesse, Bhuti Penpa, Salama Carlos
Department of Medicine, Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center, Elmhurst, NY 11373, USA.
Division of Pulmonary and Critical Care, Department of Medicine, Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center, Elmhurst, NY 11373, USA.
J Clin Med Res. 2020 Dec;12(12):809-815. doi: 10.14740/jocmr4382. Epub 2020 Dec 18.
Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide, and considerable effort is focused on identifying certain populations at increased risk. ABO blood types have been associated with disease susceptibility; however, evidence remains limited. Our aim was to determine the association between ABO/Rh blood type with disease susceptibility and mortality among admitted COVID-19 patients.
A retrospective analysis of patients with COVID-19 requiring admission was undertaken. Demographics and pertinent medical history were analyzed with respect to ABO/Rh blood type: between the cases and a control population; as well as with respect to mortality in the COVID-19 population in univariate analysis. Potential confounding factors were evaluated by multivariate models. The main outcomes were disease susceptibility by comparison of blood type prevalence between populations, and mortality within the COVID-19 population.
A total of 825 cases (admitted with confirmed COVID-19 infection by reverse transcriptase-polymerase chain reaction (RT-PCR)) and 396 controls (seen at the same institution during the calendar year of 2019) were included. The COVID-19 population was older with male predominance. It was heavily represented by blood types O-positive (53%) and A-positive (23%), while lower representation was observed in groups B-positive (odds ratio (OR): 0.61, P = 0.013) and AB-positive (OR: 0.46, P = 0.014). Neither relationship remained significant in pairwise analysis. Within the COVID-19 population, no mortality difference was appreciated between ABO groups (P = 0.312), but higher mortality was observed in Rh negative group (P = 0.01). The latter of which was significantly confounded by age (P < 0.001), sex (P = 0.022), body mass index (BMI) (P = 0.001), and hemoglobin A1c (HbA1c) (P < 0.001) in multivariate analysis.
While type A blood appears to be weakly more prevalent with respect to B and AB types in hospitalized patients, strong confounders of age and sex dilute this significance. Rh-negative patients appear to have a higher mortality, although this too is strongly confounded. Overall, ABO and Rh blood types do not have a significant relationship with susceptibility and mortality with COVID-19 infection in our population.
2019冠状病毒病(COVID-19)已影响全球数百万人,目前人们正致力于确定某些风险增加的人群。ABO血型与疾病易感性有关;然而,证据仍然有限。我们的目的是确定ABO/Rh血型与COVID-19确诊患者的疾病易感性和死亡率之间的关联。
对需要住院治疗的COVID-19患者进行回顾性分析。分析了人口统计学和相关病史与ABO/Rh血型的关系:病例组与对照组之间;以及在单因素分析中COVID-19患者群体的死亡率。通过多变量模型评估潜在的混杂因素。主要结果是通过比较人群之间的血型患病率来评估疾病易感性,以及COVID-19患者群体中的死亡率。
共纳入825例病例(通过逆转录聚合酶链反应(RT-PCR)确诊为COVID-19感染而住院)和396例对照(2019年日历年在同一机构就诊)。COVID-19患者群体年龄较大,以男性为主。O型阳性(53%)和A型阳性(23%)血型的患者占比很高,而B型阳性组(比值比(OR):0.61,P = 0.013)和AB型阳性组(OR:0.46,P = 0.014)的占比则较低。在成对分析中,这两种关系均不再显著。在COVID-19患者群体中,ABO血型组之间未观察到死亡率差异(P = 0.312),但Rh阴性组的死亡率较高(P = 0.01)。在多变量分析中,后者受到年龄(P < 0.001)、性别(P = 0.022)、体重指数(BMI)(P = 0.001)和糖化血红蛋白(HbA1c)(P < 0.001)的显著混杂影响。
虽然在住院患者中,A型血相对于B型和AB型血似乎略微更常见,但年龄和性别的强混杂因素削弱了这一显著性。Rh阴性患者的死亡率似乎较高,尽管这也受到强烈的混杂影响。总体而言,在我们的人群中,ABO和Rh血型与COVID-19感染的易感性和死亡率没有显著关系。